Dilantin



Indications and Reactions:

Role Indications Reactions
Primary
Convulsion 56.1%
Epilepsy 16.0%
Grand Mal Convulsion 6.8%
Hypertension 3.8%
Pain 2.7%
Convulsion Prophylaxis 2.1%
Ill-defined Disorder 2.1%
Depression 1.1%
Anxiety 1.0%
Cardiac Disorder 0.9%
Drug Use For Unknown Indication 0.9%
Gastrooesophageal Reflux Disease 0.9%
Prophylaxis 0.9%
Blood Cholesterol Increased 0.8%
Partial Seizures 0.7%
Petit Mal Epilepsy 0.7%
Headache 0.7%
Dementia Alzheimer's Type 0.6%
Diabetes Mellitus 0.6%
Hypothyroidism 0.6%
Stevens-johnson Syndrome 25.6%
Convulsion 19.6%
Toxic Epidermal Necrolysis 6.8%
Weight Decreased 5.2%
Tremor 4.3%
Somnolence 3.6%
Drug Ineffective 3.4%
Grand Mal Convulsion 3.4%
Weight Increased 3.3%
Vomiting 3.2%
Toxicity To Various Agents 2.7%
Drug Hypersensitivity 2.6%
Rash 2.6%
Vision Blurred 2.3%
Malaise 2.2%
Pharmaceutical Product Complaint 2.0%
Drug Level Decreased 1.8%
Visual Acuity Reduced 1.8%
Dysphagia 1.7%
Unevaluable Event 1.7%
Secondary
Convulsion 42.9%
Epilepsy 11.8%
Product Used For Unknown Indication 9.3%
Drug Use For Unknown Indication 5.9%
Hypertension 4.7%
Grand Mal Convulsion 3.5%
Pain 3.3%
Convulsion Prophylaxis 2.0%
Anxiety 2.0%
Depression 1.9%
Cardiac Disorder 1.7%
Diabetes Mellitus 1.6%
Blood Cholesterol Increased 1.5%
Urinary Tract Infection 1.5%
Headache 1.2%
Status Epilepticus 1.2%
Agitation 1.1%
Multiple Allergies 0.9%
Gastrooesophageal Reflux Disease 0.9%
Crohn's Disease 0.9%
Stevens-johnson Syndrome 45.8%
Convulsion 8.7%
Toxic Epidermal Necrolysis 7.4%
Weight Decreased 4.1%
Weight Increased 4.0%
Tremor 3.4%
Drug Ineffective 3.0%
Vision Blurred 2.8%
Vomiting 2.8%
Grand Mal Convulsion 2.0%
Somnolence 1.9%
Memory Impairment 1.8%
Pain 1.7%
Rash 1.7%
Anticonvulsant Drug Level Decreased 1.5%
Anticonvulsant Drug Level Increased 1.5%
Drug Hypersensitivity 1.5%
Fatigue 1.5%
Myocardial Infarction 1.5%
Thrombocytopenia 1.4%
Concomitant
Product Used For Unknown Indication 23.7%
Convulsion 16.3%
Drug Use For Unknown Indication 10.2%
Epilepsy 6.3%
Pain 6.1%
Depression 4.1%
Hypertension 3.9%
Multiple Sclerosis 3.5%
Osteoporosis 3.4%
Glioblastoma Multiforme 3.3%
Anxiety 3.0%
Nuclear Magnetic Resonance Imaging 2.2%
Rheumatoid Arthritis 2.1%
Asthma 2.0%
Gastrooesophageal Reflux Disease 1.9%
Blood Cholesterol Increased 1.7%
Bipolar Disorder 1.7%
Constipation 1.6%
Smoking Cessation Therapy 1.6%
Sleep Disorder 1.5%
Convulsion 15.6%
Vomiting 10.5%
Weight Decreased 7.1%
Drug Ineffective 6.7%
Weight Increased 6.3%
Somnolence 4.9%
Type 2 Diabetes Mellitus 4.8%
Death 4.4%
Tremor 4.4%
Pain 4.1%
Urinary Tract Infection 4.0%
Vision Blurred 3.9%
Nausea 3.8%
Pneumonia 3.7%
Rash 3.1%
Grand Mal Convulsion 2.7%
Pruritus 2.7%
Pyrexia 2.5%
White Blood Cell Count Decreased 2.5%
Pancreatitis 2.3%
Interacting
Convulsion 32.6%
Product Used For Unknown Indication 14.8%
Epilepsy 9.2%
Grand Mal Convulsion 7.5%
Lyme Disease 4.3%
Hypertension 4.1%
Pain 3.9%
Convulsion Prophylaxis 3.4%
Hypothyroidism 2.6%
Depression 2.1%
Sinusitis 2.1%
Hypersensitivity 1.7%
Thyroidectomy 1.7%
Anxiety 1.5%
Blood Pressure Abnormal 1.5%
Cervix Carcinoma 1.5%
Post-traumatic Epilepsy 1.5%
Back Disorder 1.3%
Drug Use For Unknown Indication 1.3%
Fungal Infection 1.3%
Drug Interaction 23.7%
Weight Increased 13.2%
Weight Decreased 9.6%
Sinusitis 7.0%
Tongue Disorder 6.1%
Feeling Abnormal 4.4%
Grand Mal Convulsion 3.5%
Hepatic Enzyme Increased 3.5%
Palpitations 3.5%
Speech Disorder 3.5%
Dizziness 2.6%
Drug Level Decreased 2.6%
Headache 2.6%
Rash Macular 2.6%
Urinary Tract Infection 2.6%
Convulsion 1.8%
Cystitis 1.8%
Drug Level Increased 1.8%
Nervousness 1.8%
Partial Seizures 1.8%